Bluesight releases its 2025 Diversion Trends Report, offering current insights into how hospitals are leveraging software and staff oversight to detect and prevent controlled substance diversion. With data from over 1100 hospitals, the report indicates that comprehensive diversion monitoring, utilizing both human resources and technology, is driving faster case resolution, improved documentation, and enhanced patient safety. Key takeaways include the following: with expanded use of diversion software tools, conducted investigations increased by 61% from 2023 to 2024, and average case closure times dropped by 40 days; variance rates are declining, with just 6% of controlled substance transactions showing discrepancies in 2024; and 67% of hospitals rely on diversion committees, with 53% using software tools to monitor and prevent diversion. The full report is available online.